Phase II Trial of Chemoimmunotherapy With 5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung Cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Fluorouracil (Primary) ; Interferon alpha-2b (Primary)
- Indications Gastrointestinal cancer; Non-small cell lung cancer; Renal cancer
- Focus Therapeutic Use
- 21 Mar 2018 Biomarkers information updated
- 18 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 18 Dec 2013 Planned end date changed from 1 Dec 2013 to 1 Jul 2014 as reported by ClinicalTrials.gov record.